Metastatic Colorectal Cancers Terminated Phase 2 Trials for Aflibercept (DB08885)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01669720Adjuvant Aflibercept for Metastatic Colorectal CancerTreatment
NCT02045030Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal CancerTreatment